Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic screening for deafness.

Richard J H Smith1, Stephen Hone

  • 1Department of Otolaryngology, Molecular Otolaryngology Research Labs, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA. richard-smith@uiowa.edu

Pediatric Clinics of North America
|June 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monoclonal nephritic factors reveal insights into C3 convertase dynamics and dysregulation.

bioRxiv : the preprint server for biology·2026
Same author

Correction: <i>Lmx1a</i> is essential for marginal cell differentiation and stria vascularis formation.

Frontiers in cell and developmental biology·2026
Same author

The AudioGene Translational Dashboard for Diagnosing Autosomal Dominant Nonsyndromic Hearing Loss: Phenotypic Data Visualization and Analysis Study.

JMIR bioinformatics and biotechnology·2026
Same author

Complement biomarkers during iptacopan treatment - Authors' reply.

Lancet (London, England)·2026
Same author

Investigation of GSDME results in the identification of the first pathogenic synonymous variants and genotype-phenotype correlations.

Human genetics·2025
Same author

Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study.

Lancet (London, England)·2025
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Genetic testing for deafness is now a reality, transforming diagnosis and treatment for hearing-impaired individuals. Future advancements will expand its role in personalized medical care and management strategies.

Area of Science:

  • Genetics
  • Otolaryngology
  • Medical Diagnostics

Background:

  • Genetic testing for deafness is increasingly available, offering new diagnostic and management pathways.
  • Current mutation screening covers a limited number of genes but provides diagnosis, carrier detection, and reproductive counseling.
  • The role of genetic testing in audiology is expanding beyond reproductive issues.

Purpose of the Study:

  • To highlight the current and future impact of genetic testing in the evaluation and management of deafness.
  • To inform otolaryngologists about the importance and evolving landscape of genetic testing.
  • To emphasize the need for physicians to stay updated on genetic testing advancements.

Main Methods:

  • Review of current genetic testing capabilities for deafness.

Related Experiment Videos

  • Discussion of diagnostic, therapeutic, and management implications.
  • Exploration of the expanding role of genetic counseling.

    • Main Results:

    • Genetic testing provides a basis for diagnosis, carrier detection, and reproductive risk assessment for specific genes.
    • Future applications will extend to treatment and management decisions based on genetic diagnoses.
    • The complexity of genetic testing is increasing with new discoveries and technologies.

    Conclusions:

    • Genetic testing is a crucial component of modern audiological care.
    • Otolaryngologists must familiarize themselves with genetic testing protocols and advancements.
    • Personalized medicine in deafness management will increasingly rely on genetic information.